Clin2
NCT07673120Possibly a fitRecruiting

Safety study of ABBV-313 in healthy adults

Healthy Volunteers

This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
64 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be in generally good health, with no major medical issues.
  • Your body mass index (BMI) must be between 18.0 and 29.9.
  • You must not have had any major illness, infection, fever, hospitalization, or surgery in the last 30 days.
  • You must not have any known significant allergies to any medication or food.
  • You must not have taken ABBV-313 in the past 300 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07306754Recruiting· Phase 1
A Safety Study of ABBV-243 in Healthy Adults

This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.

Grayslake, Illinois
NCT07662057Recruiting· Phase 1
Safety study of AB102 in healthy volunteers

This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.

Groningen
NCT07422207Recruiting· Phase 1
Safety study of ME3241 in healthy adults

This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.

Sydney, New South Wales
NCT06995326Not yet recruiting· Phase 1
Study of an experimental drug SGB-3383 in healthy volunteers

This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.

NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07283263Recruiting· Phase 1
Safety study of new drug BMS-986521 in healthy volunteers

This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.

Anaheim, California

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.